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Abstract
Environmental or occupational exposure to high levels of manganese (Mn) can lead to
manganism, a symptomatic neuro-degenerative disorder similar to idiopathic Parkinson’s disease.
The underlying mechanism of Mn neurotoxicity remains unclear. In this study, we evaluate the
primary toxicological events associated with MnCl2 toxicity in rat PC12 cells using whole genome
cDNA microarray, RT-PCR, western blot and functional studies. The results show that a sub-
lethal dose range (38–300 µM MnCl2) initiated slight metabolic stress evidenced by heightened
glycolytic rate and induction of enolase / aldolase - gene expression. The largest shift observed in
the transcriptome was MnCl2 induction of heme-oxygenase 1 (HO-1) [7.7 fold, p <0.001], which
was further corroborated by RT-PCR and western blot studies. Concentrations in excess of 300
µM corresponded to dose dependent loss of cell viability which was associated with enhanced
production of H2O2 concomitant to elevation of of gene expression for diverse antioxidant
enzymes; biliverdin reductase, arsenite inducible RNA associated protein, dithiolethione-inducible
gene-1 (DIG-1) and .thioredoxin reductase 1. Moreover, Mn initiated significant reduction of gene
expression of mitochondrial glutaryl-coenzyme A dehydrogenase (GCDH) -, an enzyme involved
with glutaric acidemia, oxidative stress, lipid peroxidation and striatal degeneration observed in
association with severe dystonic dyskinetic movement disorder. Future research will be required to
elucidate a defined role for HO-1 and GCDH in Mn toxicity.
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1. Introduction
Manganese is an essential trace metal required for proper immune function, metabolism,
reproduction, digestion, bone growth, and blood clotting (dos Santos et al., 2010).
Additionally, Mn functions as a cofactor in several enzymes such as arginase (urea
formation), glutamine synthetase (for brain ammonia metabolism), Mn superoxide
dismutase (MnSOD) (antioxidant) and phosphoenolpyruvate decarboxylase
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(gluconeogenesis) (Christianson, 1997, Paynter, 1980). While dietary intake of Mn is
essential to prevent deficiencies, exposure to high levels of Mn can be toxic leading to
irreversible neurological injury (Greger, 1999).
Chronic exposure to higher levels of Mn in occupational and environmental settings can
arise in association with steel production, gasoline anti-knock additives
(methylcyclopentadienyl manganese tricarbonyl), mining, welding, battery assembly and
glass and ceramics manufacturing (Aschner et al. , 2005). It is estimated that over 3700 tons
of Mn are released into the atmosphere every year (Sengupta et al. , 2007). High level
exposure can lead to manganism which is a progressive disease with symptoms similar to
those of Parkinson’s disease (Lucchini et al. , 1999). Typical symptoms include tiredness,
sleep disturbances, aggressiveness, and behavioral disturbances (“manganese madness”).
Delayed neurological disturbances encompass the extrapyramidal system, characterized by
walking difficulties, dystonia, and kinesia (dos Santos, Milatovic, 2010). The similarities
between symptomic cardinal signs associated with acute Mn toxicity in humans and
idiopathic PD are indicative of deficiency of dopamine in the striatum. In PD a loss of
dopamergic neurons in the SNc occurs in addition to progressive losses of the dopamine
transporter and dopa decarboxylase, where Mn accumulates in the basal ganglia, damages
the D2 receptor, inhibits the dopamine transporter and results in toxicological insult to the
globus pallidus (Ericson et al. , 2007, Guilarte, 2011, Winder et al. , 2010). While both result
in dopamine deficiency and are responsive to L-dopa therapy, there seems to be differences
in regional patterned damage associated with Mn toxicity and PD. Moreover, the leading
mechanism of manganese neurotoxicity is not clear, however, several studies have suggested
that Mn induces neuronal cell death by disrupting mitochondrial function (Malecki, 2001),
initiating oxidative stress (Chtourou et al. , 2010), altering MAPK signaling, disrupting
cellular calcium and iron homeostasis (Reaney and Smith, 2005) an initiating cytochrome c
release and apoptosis (Roth et al. , 2002).
Genomic microarrays are a valuable tool in probing or identifying molecular patterns
associated with environmental exposure to diverse toxins. In this study, we employ this
technique to elucidate the nature of changes incurred when treating PC12 cells (which
synthesize/ release catecholamines) with varying concentrations of Mn. The findings while
broad, provide general identification of major genes or protein shifts incurred by Mn, which
were corroborated by RT-PCR and immuno-blotting.
2.Materials and methods
2.1 Chemicals and Materials
Pheochromocytoma (PC12) cells (ATCC, Manassas, VA), RPMI Media 1640, horse serum
(HS), fetal bovine serum (FBS), and penicillin/streptomycin, trypan blue exclusion, tissue
culture water , MnCl2, Chloroform, Isopropyl alcohol, 10X PBS, Tween twenty, (Sigma
Chemical Company, St. Louis, MO); TrizolTMLS reagent (Gibco BRL, NY, USA);
Nuclease-free water (Ambion the RNA Company, Austin, TX); MultiScribe™ Reverse
Transcriptase (RT), 10X RT buffer, 10X random primers, 25X dNTPs, 2X Master Mix,
Probe/gene set (Assay)(Applied Biosystem, Foster City, CA); Agilent Rat cDNA
Microarray from Incyte Genomics and cDNA synthesis kit (Agilent Technologies Inc, CA),
2.2 Cell Cultures and Trypan Blue Cell Viability
PC12 cells are derived from rat adrenal medulla pheochromocytoma of dopaminergic origin,
often used as a model to study various aspects of catecholaminergic function. PC12 cells
were cultured in RPMI media supplemented with 10% HS, 5% FBS, 25 units/ml penicillin,
and 25 µg/ml streptomycin. These cells were grown at 37°C in a humidified atmosphere of
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5% CO2 incubator. The culture media was changed every 2–3 days until the cells reached
confluence. Viability of PC12 cells were assessed using Trypan Blue Exclusion. Only cells
with viability greater or equal to 90% were used to set an experiments.
2.3 RNA Extraction and Agilent Rat cDNA Microarray Analysis
To examine the effect of Mn on PC12 cells gene expression two groups of samples were
prepared as follows: (1) untreated PC12 cells, which served as controls and (2) 300µM
MnCl2 treated PC12 cells. For each group, approximately 1×107 cells were plated in
duplicate in 75cm flask and incubated overnight at 37°C to attach. The next day cells were
treated with 300µM MnCl2 and incubated again for 24 hrs. At the end of 24hr exposure to
MnCl2 total RNA was isolated using TrizolTM LS reagent following the manufacturer
protocol (Gibco BRL, NY). The integrity of the total RNA isolated was monitored using an
Agilent 2100 Bioanalyzer System; all samples exhibit a ratio of 1.9–2.1. Agilent Rat cDNA
microarray experiment analysis was performed at Wayne State University. The microarray
contained approximately 10,900 sequence- verified cDNAs from Incyte Genomic.
2.4 Microarray Data Analysis and Statistics
Microarray data were analyzed GeneSifter software ( GeneSifter is now Geospiza, Seattle,
WA.). To identify genes whose transcript level was significantly altered by Mn, we applied
three consecutive analysis processes. First, we applied pairwise analysis to identify genes
whose overall transcript level calculated from three independent experiment (Mn-treated
versus control) was altered by at least 1.5-fold. Second, Gene Ontology and z-score repot
were also generated with GeneSifter. Statistical analysis of individual gene expression data
was performed with Student’s t-test. (http://genesifter.net/datacenter/).
2.5 Validation of Heme Oxygenase cDNA results by RT-PCR
The technique RT-PCR was used to confirm the results from the cDNA microarray study,
for heme oxygenase 1 (HO-1). The primers used were as follows: Heme oxygenase 1, -
product size 376bp, forward, 5’-TTC ACC TTC CCG AGC ATC-3’ reverse 5’-TCC CAC
TGC CAC GGT C-3’; For normalization 40S ribosomal protein S29 (RPS29) housekeeping
gene was used. The primer used was, product size 276bp, forward, 5’-CTC CTT GGG CGT
CTG A-3’ reverse 5’-GCG CAA AGA CTA GCA TGA-3’. The RTPCR program included
first reverse transcription (RT) of RNA by StrataScriptTM reverse transcriptase
(StrataScriptTM RT) at 42°C for 15 minutes then PCR program follows. The amplification
program included the initial denaturation step at 95°C for 1 minute and - 30 cycles of
denaturation at 95°C for 30s, annealing at (66°C for - HO-1 and 63°C RPS29) for 30s, and
extension at − 68°c for 2 minutes and 10 minute final extension at 68°C. Aliquots of the
PCR products (20 µL) were visualized with ethidium bromide staining after separation by
electrophoresis in a 2% agarose gel in Tris borate ethylenediamine tetra-acetic acid buffer
pH 8.3 at 100V for 2 h. Images were captured by a Fluor-S Max MultiImaging system and
Band intensities were measured using Molecular Dynamics 300 Series Computing
Densitometer.
2.6 Western blotting analysis
Expression of protein level of HO-1 was assessed by Western blot analysis in PC12 cell
lysates. Total protein (20µg) was derived from cell lysates of PC12 cells treated with 38µM,
75µM, 150 µM, 300 µM, 600 µM, 1200 µM MnCl2 and control PC12 cells (no treatment)
were subjected to SDS-polyacrylaminde gel electrophoresis (PAGE) on 10%
polyacrylamide gel, then transferred to a nitrocellulose membrane. Blots were probed with
anti-heme oxygenase 1 (Santa Cruz Biotechnology, Santa Cruz, CA) overnight 4°C at a
concentration 1:800 in 5% milk/PBS with 0.05% Tween-20. The membrane was then
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incubated with anti-rat IgG horseradish peroxide-linked secondary antibody (Santa Cruz
Biotechnology, Santa Cruz, CA) at a concentration of 1:1000 for three hours at room
temperature. Blots were then rinsed thoroughly in PBS with tween-20 (PBS-T), and
visualized with chemiluminescence. The nitrocellulose membrane was then stripped at 50°C
for 30 minutes in stripping solution (2% SDS, 0.1M β-mercaptoethanol, and 0.06M TRIS,
PH 6.8), then was rinsed twice for 10 minutes with PBS with tween-20. The blots were
probed with anti-beta actin (Santa Cruz Biotechnology, Santa Cruz, CA) at a concentration
1:600 in 5% milk/PBS with tween-20 overnight at 4°C. This was followed by 3 hour
incubation with the secondary antibody anti-rat IgG (Santa Cruz Biotechnology, Santa Cruz,
CA) at a concentration of 1:1000 in 5% milk/PBS with tween-20. Blots were then rinsed
with PBS visualized by chemiluminescence and exposed to radiographic film (Kodak X-
OMAT AR). Film images were scanned and protein band intensities were quantitated using
Molecular Dynamics 300 Series Computing Densitometer.
2.7 Cell metabolism
Cell viability was assessed using resazurin (Alamar Blue) indicator dye (Evans et al. , 2001).
A working solution of resazurin was prepared in sterile PBS - phenol red (0.5 mg/ml) and
added (15% v/v) to each sample. Samples were returned to the incubator for 6–8 hr, and
reduction of the dye by viable cells (to resorufin, a fluorescent compound) was
quantitatively analyzed on a microplate fluorometer, Model 7620, version 5.02 (Cambridge
Technologies Inc, Watertown, MA) with settings at [550/580], [excitation/emission].
2.8 HPLC Quantification of Lactic Acid and Glucose
Lactate and glucose concentrations were determined using a Shimadzu HPLC system
equipped with an SPD-20A UV detector (set at 210 nm), a RID-10A 120V refractive index
detector, a workstation containing EZSTART V7.4 software and an SS420X instrument
interface docked to a Waters Autosampler Model 717 Plus (Shimadzu Scientific
Instruments, Inc. US; Waters Corp., Milford, MA). The flow rate was isocratic controlled by
a Waters Model 510 pump and set at 0.6 ml/min. The mobile phase consisted of 5 mM
sulfuric acid, the column was an aminex HPX-87H 300 × 7.8 mm, carbohydrate analysis
column, 9 µm particle size (Biorad Hercules, CA), run time was 16 min and injection
volume 25 µl. Samples were prepared by placing 35 µl cell supernatant directly into 200ul of
5mM sulfuric acid, immediately stored at –80C. Prior to analysis, samples were thawed and
125 µl, mixed with 275 µl of the 5mM sulfuric acid, vortexed, capped and analyzed. Glucose
and lactate standard curves were prepared in distilled water and matrix blank controls and
spikes were run for every experimental treatment condition tested.
2.9 Hydrogen Peroxide Measurement
Hydrogen peroxide was assessed using a chromogenic solution containing 1 mM vanillic
acid, 500µM of 4-aminoantipyrine and 4 U/ml purpurogallin of horse-radish peroxidase—
type II (Mazzio and Soliman, 2004). The combined reagent was added to each sample and
returned to the incubator, continuous endpoint analysis was monitored at 500 nm using a UV
microplate spectrophotometer, Model 7600 version 5.02, Cambridge Technologies Inc.
(Watertown, MA, USA).
3. Results
PC12 cells were exposed to MnCl2 over a concentration range of 38– 4800 µM for 24 hrs
(Figure 1). The dose dependent toxicological profile shows a sub-lethal range (38–300 µM)
with greater concentrations associated with cell death. In order to evaluate metabolic
changes altered by MnCl2, lactate and glucose concentrations in the media were evaluated
by HPLC at 24 hr (Figure 2). The data show a very slight shift toward enhanced glycolytic
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activity as evidenced by rise in lactate and expedited utilization of glucose from 38–300µM,
with losses that paralleled toxicity at higher concentration. However, these changes are very
mild in comparison to that observed with various mitochondrial toxins such as MPP+
(Mazzio and Soliman, 2003) which evoke cell death by loss of cellular respiration,
accelerated glycolysis and ultimately exhaustion of glucose supplies. In this study, losses of
glucose were meager and ample quantities of glucose remained in the media at 300µM
MnCl2 to sustain energy metabolism, indicating that energy failure is not the primary cause
of cell death.
In order to determine if production of H202 and superoxide corresponded to MnCl2 induced
cell death, free radicals were quantified. The data show that only H202 was detected after 24
Hrs, while we found no evidence for rise in superoxide using cytochrome c reduction
methods (data not shown) (Figure 3). These findings show an inverse linear relationship
between cell death and production of H202 suggesting that oxidative stress may be involved
with toxicity.
In order to gain understanding as to the molecular changes incurred by MnCl2, cDNA
microarray analysis was conducted. The data in Figs 1–3 establish 300µM to be an
appropriate concentration to capture molecular events associated with MnCl2 at
concentrations just below the threshold of toxicity (< 600µM Mn). Therefore, whole genome
microarray analysis was performed by comparing untreated controls vs PC12 cells exposed
to 300µM MnCl2. The data show that Mn significantly (p < 0.05) altered the expression of
223 genes (out of 10,900 genes) whose overall expression level was >1.5- fold. Of these 223
genes, 146 were up-regulated while 77 were down-regulated. Sixty nine of these genes were
expressed at more than two folds, and an additional 16 genes were expressed at greater than
three fold with the highest for heme oxygenase 1 (H0-1) (7.70-fold increase). Genes which
displayed differential patterns (p<.05) involved in either metabolism or antioxidant response
are presented in Table 1. HO-1 has the highest gene expression (7.70-fold increase).
In order to further corroborate the effects of MnCl2 on HO-1, RT-PCR was performed
(Figure 4A, 4B), followed by protein expression analysis using SDS-PAGE/Western blot
(Figure 5 A–C). Both RT-PCR and western blot findings are consistent with gene expression
profile showing greatest HO-1 expression at 300µM MnCl2 , non – existent in controls,
where induction occurred at 12h but reached a maximum value at 18–24 hrs. The results
from these studies suggest that HO-1 plays a predominant role, albeit not well understood, in
molecular effects of MnCl2 in PC12 cells.
4. Discussion
The purpose of the present study was to evaluate the primary toxicological events associated
with Mn toxicity in rat PC12 cells using cDNA microarray, RT-PCR, western blot and
functional studies. These findings show that Mn toxicity is primarily associated with
induction of heme oxygenase 1 , elevated production of H202, with very slight effects on
loss of mitochondria with exception for loss of mitochondrial glutaryl-CoA dehydrogenase
(GCDH), reduction which is typically associated with striatal lesions specific to the basal
ganglia (Strauss et al. , 2007). The findings in this study corroborate a number of previous
studies having demonstrated that toxicity of Mn is associated with induction of HO-1
(Satarug et al. , 2008) and greater oxidative stress as evidenced by lipid peroxidation,
reduction of endogenous antioxidants system (SOD, CAT, GPx) and depletion of
antioxidants (GSH, Vit C) (Chtourou, Fetoui, 2010). However, the data do not provide
evidence to support Mn induced production of superoxide, or expression of MnSOD,
although these effects have been reported in other models (Chiu et al. , 2002, Hussain and
Ali, 1999, Methy et al. , 2004).
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The largest shift in the genome was Mn induced up-regulation of HO-1. It is believed that
HO-1 can serve as an antioxidant due to its ability to degrade the oxidant heme. Unbound
heme is associated with the pathology of oxidative stress disorders, where a rise in HO-1
results in its removal with subsequent conversion to carbon monoxide (CO), ferrous iron
(Fe2+) and biliverdin. In turn, biliverdin is converted to bilirubin (antioxidant) by biliverdin
reductase (Pae and Chung, 2009). HO-1 is also considered an anti-inflammatory due to its
down-regulation of cyclooxygenase-2 and a number of pro-inflammatory cytokines (tumor
necrosis factor-α, interleukins 1–6) (Vijayan et al. , 2010).
The signaling pathways which control induction of HO-1 are largely mediated by the
antioxidant response element (ARE) pathway controlled by nuclear localization and binding
of nuclear factor-erythroid 2-related factor 2 (Nrf2) transcription factor, both co-expressed
in various biological tissue, showing potent downregulators of ROS and lipid peroxidative
damage (Li et al. , 2011c). A loss of the ARE antioxidant pathway, for example in Nrf2(−/−)
mice establishes greater vulnerability to a number of degenerative pathologies (Zhao et al. ,
2011). Li et al. have shown that in PC12 cells, the effects of Mn on induction of HO-1 are in
fact mediated through Nrf2-ARE pathway (Li et al. , 2011b). Nrf2 is multifunctional, and
can also up-regulate a host of related protective elements such as phase II detoxification
enzymes, glutathione peroxidase (GPX) , γ-GCS (Li et al. , 2011a) and biosynthesis of
intracellular glutathione (Collinson et al. , 2011, Escartin et al. , 2011). Moreover, additional
down stream effects of the Nrf2-ARE include the Kelch-like ECH-associated protein 1,
NADPH: quinone oxidoreductase 1, activating transcription factor 3, peroxiredoxins 3/6 and
catalase (Maruyama et al. , 2011). In general, previous reports are consistent in
demonstrating that Nrf2 controls HO-1 induction (Zhang et al. , 2007) , antioxidant systems
through Akt, extra-cellular signal-regulated protein kinase1/2 (ERK1/2) and p38-MAPK (Na
et al. , 2008). (Izumi et al. , 2011, Jiang and Dai, 2011, Mizuno et al. , 2011). Further it has
been reported that Nrf-2 induction HO-1 is regulated by ERK (Chin et al. , 2011).
The findings in the current study bring forth a number of questions regarding a role for
HO-1 during Mn exposure. First, - what is the origin of peroxide, does it occur through Mn -
autoxidation of dopamine or another biological means. Second, since HO enzymes (HO-1
and HO-2) degrade heme into biliverdin, carbon monoxide and iron (Motterlini et al. , 2005,
Wang, 2010), CO in turn could be a component to the moderate loss of mitochondrial
respiratory function as observed in this study. The data in this study, show a very mild shift
toward anaerobic systems in the presence of Mn that are atypical to mitochondrial toxins
such as MPP+ (Mazzio and Soliman, 2003). The toxicological profile of a mitochondrial
toxin is associated with extremely high levels of lactic acid, that correspond to inverse
exhaustion of glucose supply – where cell starvation is the cause of cell death. In this study,
toxicity occurs at a dose of Mn where abundant glucose is still present, but where high
concentrations of H202 predominate. The potentiating effects of Mn on HO-1 could also
generate free ferrous iron, which could interact with H202 in fenton reactions to generate
toxic hydroxyl radicals (Whittle and Varga, 2010). For these reasons, it remains unclear as
to if HO-1 is detrimental or protective.
In this study, differential expression in the genome show an up-regulation of additional
antioxidant related proteins. For example Mn induction of dithiolethione-inducible gene-1
(DIG-1). DIG-1 is a component of detoxification through NAD(P)H-dependent alkenal /one
oxidoreductase which can also attenuate lipid peroxidation by antagonizing products such as
4-hydroxy-2-nonenal and acrolein (Dick et al. , 2001). The sequence of DIG-1 is similar to
leukotriene B4 (LTB4) B12-hydroxydehydrogenase, which can convert LTB4 to 12-oxo-
LTB4 and remove free radicals (Primiano et al. , 1998).. There was also an upregulation of
genes protecting against metal toxicity such as the case of arsenite inducible RNA associated
protein (Airap). Airap is associated with higher expression levels of HO-1, γ-
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glutamylcysteine and metallothioneins a part of a metal/ROS detoxification system which
involves NFκB or eIF2α signaling, and expression of CHOP/GADD153 genes (Sok et al. ,
2001) Future research will be required to assess if Mn induction of HOX-1 in PC-12 cells
involves these pathways.
Genomic analysis provided evidence for several points of mitochondrial transcription
repression. A large fold change was observed for mitochondrial glutaryl-coenzyme A (CoA)
dehydrogenase (GCDH). GCCH is involved with decarboxylation reactions yielding
products such as crotonyl-CoA, or dehydrogenation without release of CO2 forming
glutaconyl-CoA (Schaarschmidt et al. , 2011). The function of this protein is not well
known, however autosomal recessive disorders which involve a mutation or loss of function,
correlated to glutaric aciduria type 1 (GA1). GA1 is associated with accumulation of
dicarboxylates glutaric acid and 3-hydroxyglutaric acid , largely in the brain which could
adversely affect succinate transport systems and striatal complex II function (Bjugstad et
al. , 2006, Lamp et al. , 2011) In this study, we also saw adverse effects specific to genome
for transcription of complex II. One of the main symptoms of GA1 or GCDH deficiency is a
sudden onset of dystonia which results from striatal lesions concurrent to damage to the
basal ganglia, (Strauss, Lazovic, 2007). Accumulation of glutaric acid causes neurotoxicity
in the basal ganglia and fronto-temporal cortex which is associated with the progressive
dystonia, hypotonia, seizures. (de Luis et al. , 2007) and motor disability associated with
signal abnormalities in the putamen, caudate, pallidum and ventricles (Harting et al. , 2009).
Moreover, elevation of glutaric acid and 3-hydroxyglutaric acid are associated with
thiobarbituric acid-reactive substances (lipid peroxidation) in astroglioma (Quincozes-
Santos et al. , 2010) and elevated levels of H202 and malondialdehyde in striatal
homogenates (Latini et al. , 2005), Future research will be required to evaluate if glutaric
acid is associated with the elevation of H202 in Mn treated PC12 cells.
In conclusion the results from this work suggest that MnCl2 toxicity is associated with
induction of HO-1 and elevated production of H202, with very slight effects on loss of
mitochondrial function. Future research will be required to determine in depth signaling
systems involved with this response.
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Toxicity of MnCl2 on PC12 Cells after 24 Hrs incubation. The data represent cell viability
as % Control and are presented as the Mean ± S.E.M , n=4. Differences from the control
were analyzed using a one-way ANOVA followed by a Tukey post hoc test. * p<.05.
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Change of glucose consumption/ lactic acid production profile in MnCl2 treated PC12 cells
at 24 Hrs incubation. The data represent concentration of glucose mM or lactate mM in the
supernatant and are presented as the Mean ± S.E.M , n=4.
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MnCl2 Toxicity in PC12 cells relative to H202 production after 24 Hr. The data represent
cell viability as [% Control] and H202 [O.D. 500 nm] produced and are presented as the
Mean ± S.E.M , n=4. Differences from the control were analyzed using a one-way ANOVA
followed by a Tukey post hoc test. * p<.05.
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HO-1 expression in MnCl2 treated PC12 cells after 24 Hrs incubation. Verification of
altered gene expression of array was performed by RT-PCR. HO-1 band intensities were
measured using Molecular Dynamics 300 Series Computing Densitometer (4A), normalized
against corresponding RPS29 housekeeping bands (4B). The data represent the Mean ±
S.E.M , n=3 and difference from the control was analyzed using a students t-test. * p<.05.
Taka et al. Page 14














HO-1 protein expression in MnCl2 treated PC12 cells. Verification of altered protein
expression was performed by western blot analysis, relative to β-actin loading controls.
HOX-1 expression was monitored by dose (5A) , confirmed at 300µM MnCl2 (5B) where
the data represent band intensities and are presented as the mean ± S.E.M , n=3. The
difference from the control was analyzed using a students t-test. * p<.05. Time dependent
[30 m – 24 Hrs] HOX-1 induction using 300µM MnCl2 was also assessed (5C).
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Table 1
Differential gene expression profiles in PC12 cells treated with 300µM MnCl2 vs untreated Controls for 24
Hrs.
Gene Description % Change p-value
Oxidative Stress heme oxygenase (decycling) 1
dithiolethione-inducible gene-1 (DIG-1).
acid phosphatase 5, tartrate resistant





















Gene Description % Change p-value
Glycolysis Mouse hypoxia induced gene 2 (Hig2)
Aldo-keto reductase family 1, member B1 (aldose reductase)














Mitochondrial Glutaryl-Coenzyme A dehydrogenase mitochondrial transcript variant 1
ATP synthase, H+ transporting, mitochondrial F1, gamma polypeptide 1
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